Patient-Reported Function, HRQoL, and Symptoms With Pertuzumab Plus Trastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Patient-Reported Function, Health-Related Quality of Life, and Symptoms in APHINITY: Pertuzumab Plus Trastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer
Br. J. Cancer 2021 Apr 07;[EPub Ahead of Print], J Bines, E Clark, C Barton, E Restuccia, M Procter, A Sonnenblick, D Fumagalli, D Parlier, A Arahmani, J Baselga, G Viale, LL Reaby, E Frank, RD Gelber, M Piccart, C Jackisch, JA PetersenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.